Publication Name	World Journal of Gastroenterology
Manuscript ID	14621
Country	Italy

Received	2014-10-16 08:50
Peer-Review Started	2014-10-18 13:18
To Make the First Decision	2014-12-02 09:24
Return for Revision	2014-12-03 16:33
Revised	2014-12-05 22:37
Second Decision	2015-04-10 11:10
Accepted by Journal Editor-in-Chief	2015-04-11 11:00
Accepted by Company Editor-in-Chief	2015-04-17 15:56
Articles in Press	2015-04-17 16:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-05-11 13:49
Publish the Manuscript Online	2015-05-20 17:01

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Review
Article Title	Gastric cancer and the epoch of immunotherapy approaches
Manuscript Source	Invited Manuscript
All Author List	Elena Niccolai, Antonio Taddei, Domenico Prisco and Amedeo Amedei
Funding Agency and Grant Number	Funding Agency Grant Number Italian Ministry of University and Research Prin 2009FZZ4XM_002
Corresponding Author	Dr. Amedeo Amedei, Department of Experimental and Clinical Medicine, University of Florence Largo Brambilla 3, 50134 Firenz, Italy. aamedei@unifi.it
Key Words	Gastric cancer; Immunotherapy; Monoclonal antibodies; T cells; Dendritic cells; NK cells
Core Tip	The overall 5-year survival rate of gastric cancer after surgery resection remains poor (~ 20–25%) also adopting different treatment strategies, such as adjuvant chemotherapy, adjuvant chemo-radiotherapy and perioperative chemotherapy. Several data support the idea that anti-GC specific immunotherapy could be an interesting therapeutic strategy. In this review, we provide a panoramic view of the various immune-based approaches adopted and the results obtained in the most significant clinical trials with GC patients.
Publish Date	2015-05-20 17:01
Citation	Niccolai E, Taddei A, Prisco D, Amedei A. Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol 2015; 21(19): 5778-5793
URL	http://www.wjgnet.com/1007-9327/full/v21/i19/5778.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i19.5778

Full Article (PDF)	WJG-21-5778.pdf
Full Article (Word)	WJG-21-5778.doc
Manuscript File	14621-Review.docx
Answering Reviewers	14621-Answering reviewers.pdf
Audio Core Tip	14621-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	14621-Copyright assignment.pdf
Copyright License Agreement	14621-Copyright assignment.pdf
Peer-review Report	14621-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	14621-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16421-Scientific misconduct check.pdf
Scientific Editor Work List	14621-Scientific editor work list.pdf